Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019Emma Nichols, Vera Marisa Costa, Jaimie D Steinmetz et al.|The Lancet Public Health|2022Cited by 5.1k
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019Jonathan Kocarnik, Etsay Woldu Anbesu, Kelly Compton et al.|JAMA Oncology|2021Cited by 2k
Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease StudyRupert Bourne, Joshua R. Ehrlich, Ashkan Afshin et al.|The Lancet Global Health|2020Cited by 1.3k
Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019Hmwe Hmwe Kyu, Hanadi Al Hamad, Avina Vongpradith et al.|The Lancet Infectious Diseases|2022Cited by 312
Use of multidimensional item response theory methods for dementia prevalence prediction: an example using the Health and Retirement Survey and the Aging, Demographics, and Memory StudyFlorian Fischer, Emma Nichols, Foad Abd-Allah et al.|BMC Medical Informatics and Decision Making|2021Cited by 8